Search

Your search keyword '"Ramage, Paul"' showing total 117 results

Search Constraints

Start Over You searched for: Author "Ramage, Paul" Remove constraint Author: "Ramage, Paul"
117 results on '"Ramage, Paul"'

Search Results

1. Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β

2. Discovery of selective low molecular weight interleukin-36 receptor antagonists by encoded library technologies.

3. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

4. Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches

5. MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans

9. Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

13. Affinity classification of kinase inhibitors by mass spectrometric methods and validation using standard [IC.sub.50] measurements

14. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

15. Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach

19. Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases

20. Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors

27. Discovery and Structure-Based Optimization of Adenain Inhibitors

30. Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs

31. Cover Picture: Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs (ChemMedChem 2/2006)

32. Structure-Based Design, Synthesis, and Memapsin 2 (BACE) Inhibitory Activity of Carbocyclic and Heterocyclic Peptidomimetics

33. Selective Estrogen Receptor Modulators with Conformationally Restricted Side Chains. Synthesis and Structure−Activity Relationship of ERα-Selective Tetrahydroisoquinoline Ligands

34. Structural Biology of Protein Tyrosine Kinases.

35. Structural Biology of Protein Tyrosine Kinases.

36. Heterologously expressed inner lipoyl domain of dihydrolipoyl acetyltransferase inhibits ATP-dependent inactivation of pyruvate dehydrogenase complex

44. The likelihood of aggregation during protein renaturation can be assessed using the second virial coefficient.

45. Asymmetric Flow Field-Flow Fractionation (AF4) with Multi-Angle Light Scattering (MALS) tor High-Throughput Protein Refolding.

48. Factors impacting on the adoption and operation of corporate governance reform in Australian state government departments

49. Remedial strategies in structural proteomics: Expression, purification, and crystallization of the Vav1/Rac1 complex

50. Discovery of 4-((2 S ,4 S )-4-Ethoxy-1-((5-methoxy-7-methyl-1 H -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases.

Catalog

Books, media, physical & digital resources